Valuation: Burning Rock Biotech Limited

Market Cap 96Cr 14Cr 12Cr 12Cr 11Cr 20Cr 1.37TCr 20Cr 140.73Cr 54Cr 698.28Cr 54Cr 52Cr 2.24TCr P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 52Cr 7.74Cr 6.76Cr 6.38Cr 5.8Cr 11Cr 742.34Cr 11Cr 76Cr 29Cr 378.69Cr 29Cr 28Cr 1.21TCr EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+5.29%
1 week+22.50%
Current month+50.63%
1 month+56.43%
3 months+102.20%
6 months-23.26%
Current year-29.35%
1 week 10.7
Extreme 10.7004
14.79
1 month 9.11
Extreme 9.108
14.79
Current year 6.79
Extreme 6.79
41.72
1 year 6.79
Extreme 6.79
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
206
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Date Insider Type Main position Quantity % Market Cap. Importance
31/03/26 Buy

Chief Executive Officer

3,14,870 0.3584%
18/03/26
Northern Light Venture Capital Development Ltd.
OtherCompany 1,18,80,245 13.5213%
17/03/26 Other

Director

22,718 0.0259%
Change 5-day change 1-year change 3-year change Capi.($)
+5.29%+22.50%+72.13%+42.35% 14Cr
+0.84%+13.26%+110.56%+617.26% 5.28TCr
-0.63%+4.48%+16.17%+59.04% 2.62TCr
-1.94%-0.67%-13.53%-37.98% 689.49Cr
-2.29%+2.32%+1.06%+166.57% 612.11Cr
-1.44%-1.03%+16.33%+62.42% 335.74Cr
-3.67%+20.41%-20.97%+2,208.22% 312.99Cr
+0.10%+13.06%+145.50%+47.92% 255.54Cr
+14.45%+1.52%+37.67%+46.04% 226.12Cr
+3.13%+7.32%-11.11%-53.18% 184.93Cr
Average +1.38%+8.25%+35.38%+315.87% 1.05TCr
Weighted average by Cap. +0.22%+8.99%+62.78%+400.34%

Financials

2024 2025
Net sales 52Cr 7.7Cr 6.73Cr 6.35Cr 5.77Cr 11Cr 738.36Cr 11Cr 76Cr 29Cr 376.66Cr 29Cr 28Cr 1.21TCr 54Cr 8.06Cr 7.04Cr 6.64Cr 6.03Cr 11Cr 772.35Cr 11Cr 79Cr 31Cr 394Cr 30Cr 30Cr 1.26TCr
Net income -35Cr -5.18Cr -4.52Cr -4.26Cr -3.87Cr -7.24Cr -496.17Cr -7.27Cr -51Cr -20Cr -253.11Cr -19Cr -19Cr -811.86Cr -5.53Cr -82.64L -72.16L -68.09L -61.87L -1.16Cr -79Cr -1.16Cr -8.14Cr -3.15Cr -40Cr -3.1Cr -3.04Cr -129.63Cr
Net Debt -47Cr -7.07Cr -6.18Cr -5.83Cr -5.29Cr -9.89Cr -678.02Cr -9.94Cr -70Cr -27Cr -345.87Cr -27Cr -26Cr -1.11TCr -44Cr -6.54Cr -5.71Cr -5.38Cr -4.89Cr -9.14Cr -626.5Cr -9.18Cr -64Cr -25Cr -319.59Cr -25Cr -24Cr -1.03TCr
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
18/26/18 $14.24 +5.29% 23,990
17/26/17 $13.52 +7.99% 5,247
16/26/16 $12.52 +7.19% 50,520
15/26/15 $11.68 +0.69% 8,228
14/26/14 $11.60 -5.54% 2,38,834
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!